Evocutis has recently secured ten new contracts with a total value of £280,000, including early direct sales of LabSkinTM our living skin equivalent model.Individual contract values range from £9,000 to £88,000 and involve work across all the company's areas of expertise, including LabSkinTM, microbial and clinical microbial contract research.Work being undertaken will assess products in global consumer health, cosmetics and pharmaceuticals, and ranges from exploratory research to product development analysis.

Click here for full press release.

distributed by